CHARLOTTESVILLE, Va., Oct. 4, 2011 /PRNewswire/ -- ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced that Gary Levine has been appointed Chief Financial Officer. ZyGEM also announced that Jeffrey A. Hickey has joined the company as Director of Reagents Development for Forensics.
In collaboration with Lockheed Martin, ZyGEM is developing an innovative Rapid DNA analysis system, which is in the pre-production integration and validation phase. ZyGEM also develops and markets proprietary technologies for the extraction of DNA and RNA from diverse samples using thermophilic enzymes. The unique properties of the company's prepGEM®, forensicGEM®, livestockGEM® and RNAGEM® families of nucleic acid extraction kits make possible cost effective and flexible solutions for researchers performing a wide variety of life sciences and biomedical studies, including human genotyping, animal testing and basic research.
"We are delighted to welcome Gary and Jeff to the ZyGEM team at an especially exciting time for the company," said Paul Kinnon, CEO of ZyGEM. "Gary's strong financial and strategic background will be invaluable as we continue to grow the company and expand the scope of our activities. Jeff's extensive expertise in DNA forensics will make him a key contributor both to our growing sample preparation reagent business and to our accelerating efforts to begin commercializing the Rapid DNA platform we are developing with Lockheed Martin in the coming year."
Prior to joining ZyGEM, Mr. Levine served as Chief Financial Officer and Treasurer of Bostwick Laboratories, a clinical pathology laboratory services company. There, he was responsible for setting and driving business strategy, as well as directing the company's financial infrastructure. During his tenure, Mr. Levine p
|SOURCE ZyGEM Corp. Ltd.|
Copyright©2010 PR Newswire.
All rights reserved